Rxsight Inc (RXST) Stock Price, Quote & News

Company Profile

RxSight, Inc., a commercial-stage medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight Light Adjustable Lens (LAL), an intraocular lens made of photosensitive material that changes shape in response...

Industry: Medical Devices

Sector: Healthcare

Phone: 949 521 7830

Website: www.rxsight.com

Address:

100 Columbia, Aliso Viejo, United States

OfficialStocktwitsUser Jan. 16 at 4:23 PM

$RXST RSI: 40.72, MACD: -0.4033 Vol: 0.93, MA20: 10.53, MA50: 10.80 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

RunnerSignals Jan. 12 at 9:36 PM

Oversold Bounce Watch $RXST $DDOG $ZBIO $LOGI $CSGP RSI washed out then buyers showed up Is this the start of real rebounds or just a pause before the next move Dive into the full analysis https://stocksrunner.com/news/2026-01-12-oversold-stocks-to-buy-as-rsi-rebounds-signal-entries

0 · Reply

drockafeller Jan. 12 at 8:59 PM

$RXST Movement in the right direction!

0 · Reply

Stock_Catcher Jan. 12 at 3:00 PM

$RXST trending

0 · Reply

Siesta94 Jan. 9 at 3:13 PM

$RXST Alcon could buyout RxSight now that they no longer can take over Staar Surgical !!

1 · Reply

nineballer Jan. 9 at 3:13 PM

$RXST What happened today?

0 · Reply

sstephen Jan. 9 at 3:08 PM

$RXST please short this back to the 6’s for me. Getting cash ready to buy.

1 · Reply

BillionerOfKing Dec. 30 at 12:21 AM

$RXST Current Stock Price: $10.74 Contracts to trade: $10 RXST Jan 16 2026 Call Entry: $2.13 Exit: $2.77 ROI: 30% Hold ~22 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

FrequentistFathom Dec. 26 at 7:07 AM

$RXST Volatility reflects unresolved questions around how strategy converts into durable results. Strategic direction should avoid unnecessary detours. Visible traction across indicators would support the story. Proof, rather than potential, becomes the key differentiator.

0 · Reply

sstephen Dec. 23 at 7:44 PM

$RXST what changes made a drastic decrease happen.

1 · Reply

RxSight, Inc. (RXST) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Jan 11, 2026, 9:30 AM EST - 5 days ago

RxSight, Inc. Announces Preliminary Q4 and 2025 Financial Results; New Chief Financial Officer

Jan 2, 2026, 4:05 PM EST - 14 days ago

RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference

Dec 22, 2025, 5:15 PM EST - 25 days ago

RxSight, Inc. Announces Chief Financial Officer Transition

Nov 20, 2025, 4:05 PM EST - 2 months ago

RxSight, Inc. to Present at the Piper Sandler Healthcare Conference

Nov 5, 2025, 8:51 PM EST - 2 months ago

RxSight, Inc. (RXST) Q3 2025 Earnings Call Transcript

Nov 5, 2025, 4:05 PM EST - 2 months ago

RxSight, Inc. Reports Third Quarter 2025 Financial Results

Oct 22, 2025, 4:05 PM EDT - 3 months ago

RxSight, Inc. to Report Third Quarter 2025 Financial Results on November 5, 2025

Oct 16, 2025, 4:05 PM EDT - 3 months ago

RxSight, Inc. to Feature Live Learning Sessions at American Academy of Ophthalmology 2025 Annual Meeting

Sep 22, 2025, 8:49 AM EDT - 4 months ago

The Bottom Fishing Club - RxSight: A Ski-Jump Reversal Pattern?

Sep 22, 2025, 4:24 AM EDT - 4 months ago

RxSight, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - RXST

Sep 21, 2025, 7:22 AM EDT - 4 months ago

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of RxSight

Sep 16, 2025, 5:06 PM EDT - 4 months ago

DEADLINE NEXT WEEK: Berger Montague Advises RxSight, Inc. (NASDAQ: RXST) Investors to Contact the Firm Before September 22, 2025

Sep 14, 2025, 7:17 AM EDT - 4 months ago

RXST STOCK NEWS: RxSight, Inc. Investors Urged to Act by September 22 Court Deadline -- Contact BFA Law if You Suffered Losses

Sep 12, 2025, 8:18 AM EDT - 4 months ago

RXST SECURITIES NOTICE: Did RxSight, Inc. Mislead Investors? Contact BFA Law if You Lost Money on Your Investment

Sep 8, 2025, 1:01 PM EDT - 4 months ago

RxSight, Inc. (RXST) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Sep 6, 2025, 9:00 AM EDT - 4 months ago

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of RxSight

Sep 6, 2025, 7:18 AM EDT - 4 months ago

RXST LAWSUIT NOTICE: Lose Money on RxSight, Inc.? Contact BFA Law Prior to September 22 Legal Deadline (NASDAQ:RXST)

Sep 4, 2025, 8:45 AM EDT - 4 months ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of September 22, 2025 in RxSight, Inc. Lawsuit - RXST

Aug 29, 2025, 7:07 AM EDT - 5 months ago

RXST SHAREHOLDERS: RxSight, Inc. Investors may have been Affected by Fraud – Contact BFA Law by September 22 Court Deadline (NASDAQ:RXST)

Aug 25, 2025, 4:05 PM EDT - 5 months ago

RxSight, Inc. to Present at the Morgan Stanley Healthcare Conference

Aug 23, 2025, 7:08 AM EDT - 5 months ago

RXST CLASS REMINDER: Suffer Losses on Your RxSight, Inc. Investment? Contact BFA Law before the September 22 Court Deadline (NASDAQ:RXST)

Aug 22, 2025, 10:25 AM EDT - 5 months ago

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of RxSight

Aug 21, 2025, 7:05 AM EDT - 5 months ago

Shareholders who lost money on their RxSight, Inc. (NASDAQ: RXST) Investment Should Contact Wolf Haldenstein Immediately as the Lead Plaintiff Deadline is September 22nd

Aug 13, 2025, 8:33 AM EDT - 5 months ago

RXSIGHT STOCK: Lose Money on Your RxSight, Inc. (NASDAQ:RXST) Investment? Contact BFA Law before the September 22 Legal Deadline

Aug 11, 2025, 8:18 AM EDT - 5 months ago

RXST COURT NOTICE: RxSight, Inc. Investors may have been Affected by Fraud -- Contact BFA Law before September 22 if You Suffered Losses (NASDAQ:RXST)

Aug 8, 2025, 2:29 PM EDT - 5 months ago

RxSight, Inc. (RXST) Q2 2025 Earnings Call Transcript

Aug 7, 2025, 4:05 PM EDT - 5 months ago

RxSight, Inc. Reports Second Quarter 2025 Financial Results

Aug 4, 2025, 8:05 AM EDT - 5 months ago

RxSight, Inc. Appoints Raymond W. Cohen to Its Board of Directors

Jul 30, 2025, 8:36 AM EDT - 6 months ago

RXST INVESTORS: RxSight, Inc. (NASDAQ:RXST) Investors may have been Affected by Fraud – Contact BFA Law by September 22 about Potentially Recovering Losses

Jul 28, 2025, 8:36 AM EDT - 6 months ago

RXST LAWSUIT: RxSight, Inc. Sued for Fraud after LDD Sales Plummet – Contact BFA Law by September 22 Court Deadline (NASDAQ:RXST)

Jul 25, 2025, 2:26 PM EDT - 6 months ago

Berger Montague PC Investigates Securities Claims Against RxSight, Inc. (NASDAQ: RXST)

Jul 23, 2025, 4:56 PM EDT - 6 months ago

RxSight, Inc. Investors: Company Investigated by the Portnoy Law Firm

Jul 23, 2025, 11:50 AM EDT - 6 months ago

RXSIGHT, INC. (NASDAQ: RXST) INVESTOR ALERT Investors With Large Losses in RxSight Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights

OfficialStocktwitsUser Jan. 16 at 4:23 PM

0 · Reply

RunnerSignals Jan. 12 at 9:36 PM

0 · Reply

drockafeller Jan. 12 at 8:59 PM

$RXST Movement in the right direction!

0 · Reply

Stock_Catcher Jan. 12 at 3:00 PM

$RXST trending

0 · Reply

Siesta94 Jan. 9 at 3:13 PM

$RXST Alcon could buyout RxSight now that they no longer can take over Staar Surgical !!

1 · Reply

nineballer Jan. 9 at 3:13 PM

$RXST What happened today?

0 · Reply

sstephen Jan. 9 at 3:08 PM

$RXST please short this back to the 6’s for me. Getting cash ready to buy.

1 · Reply

BillionerOfKing Dec. 30 at 12:21 AM

0 · Reply

FrequentistFathom Dec. 26 at 7:07 AM

0 · Reply

sstephen Dec. 23 at 7:44 PM

$RXST what changes made a drastic decrease happen.

1 · Reply

Barkingdogs Dec. 11 at 8:38 PM

$RXST MY EYE SURGEON says these are the best!!! RxSight, Inc. is an Aliso Viejo, California-based medical technology company that manufactures the Light Adjustable Lens (LAL), the first and only intraocular lens (IOL) that can be customized after cataract surgery to fine-tune vision. The company's technology allows surgeons to adjust the lens's power using light, enabling patients to achieve optimized vision for their specific needs and lifestyle. Core Product: The Light Adjustable Lens (LAL) and its Light Delivery Device (LDD). Function: The LAL is implanted during cataract surgery, and its power is adjusted post-operatively with light treatments to correct residual astigmatism and improve uncorrected visual acuity. Mission: To revolutionize cataract surgery by giving patients and surgeons the ability to customize vision after the procedure. Industry: Medical Equipment Manufacturing, specifically in ophthalmology.

0 · Reply

No_Body_Knows Dec. 11 at 8:13 PM

$RXST just checking in looking good 👍

0 · Reply

SuperGreenToday Dec. 10 at 2:31 PM

$RXST Share Price: $12.35 Contract Selected: Jun 18, 2026 $10 Calls Buy Zone: $1.53 – $1.89 Target Zone: $2.58 – $3.15 Potential Upside: 59% ROI Time to Expiration: 189 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

MB0000 Dec. 6 at 6:39 PM

$RXST $36

0 · Reply

drockafeller Dec. 5 at 3:20 PM

$RXST Very curious what's driving the recent run up...

2 · Reply